DevvStream

CANNARA BIOTECH (OTCMKTS: LOVFF) STOCK QUOTE

Last Trade: US$0.70
Volume: 0
5-Day Change: -1.00%
YTD Change: -1.00%
Market Cap: US$62.630M

LATEST NEWS FROM CANNARA BIOTECH

GreenStockNews
Record Q1 net revenues of $19.5 million , representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023 Q1 operating income of $3.4 million , representing an 201% increase compared to the $1.1 million of operating income generated in Q1 2023 Delivered an eleventh consecutive quarter of... Read More
MONTREAL , Jan. 8, 2024 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced it has retained Independent Trading Group ("ITG") to provide market making services in accordance... Read More
MONTREAL , Dec. 13, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host the Company's annual general meeting of shareholders on January 25th, 2024 at... Read More
MONTREAL , Dec. 11, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada, and the largest in Quebec, today announced that it will host a webcast investor presentation on Thursday, December 14 th , 2023, at 2:00 PM ET.... Read More
Record Q4 and year end net revenues of $18.3 million and $57.6 million , representing a 53% and 60% increase compared to the same periods of 2022 Sequentially, Q4 showed significant growth over Q3 2023 with higher net revenues by 15%, operating income by 36%, Adjusted EBITDA by 26% and net income by 58% Delivered a tenth consecutive quarter of positive Adjusted EBITDA of $4.9 million Generated a record quarterly net income... Read More
Three- and nine-month net revenue were $15.9 million and $39 .3 million, a 57% and 63% increase compared to the same periods of prior year Delivered its ninth consecutive quarter of positive Adjusted EBITDA of $3.9 million, a 129% increase compared to Q3 2022 Generated Q3 2023 net income of $2.9 million and free cash flow of $3.2 million Reached an annual production capacity of 30,500 kg of premium-grade cannabis per year,... Read More
Montreal, Quebec--(Newsfile Corp. - May 23, 2023) - Cannara Biotech Inc (TSXV: LOVE) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 meetings. Cannara Biotech Inc is scheduled to present on June 7th at 3:00 PM PT.... Read More
MONTREAL , May 11, 2023 /PRNewswire/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its upcoming participation at Canaccord Genuity's 7 th annual global cannabis conference.... Read More
MONTREAL , May 4, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., announced today that they have raised an additional $10 million of credit facilities from its lead bank, BMO... Read More
MONTREAL , April 25, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that it will host a webcast investor presentation on Thursday, May 4 th , 2023, at 2:00 PM ET.... Read More
GreenStockNews
Six-month net revenues of $23.4 million , a 67% increase compared to first half 2022 Delivered its eighth consecutive quarter of positive Adjusted EBITDA of $3.2M, a 1500% increase compared to Q2 2022 Continued to increase growing capacity to meet customer demand by activating an additional growing zone in its expanding... Read More
MONTREAL , Feb. 28, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec , today announced that it has entered into an automatic share purchase plan (" ASPP ") with Raymond James Ltd. ("... Read More
MONTREAL , Feb. 10, 2023 /CNW/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., announced today that further to its news release dated January 11, 2023 , the Company held its annual shareholder... Read More
GreenStockNews
Company recorded $10.3 million in quarterly revenue; a 57% increase compared to Q1 2022 Delivered its seventh consecutive quarter of positive Adjusted EBITDA of $1.7M and reported positive net income for a second consecutive quarter Continued to increase growing capacity to meet customer demand by activating new growing zone... Read More
MONTREAL , Jan. 12, 2023 /CNW/ - Cannara Biotech Inc . (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announces details of its proposal to consolidate all of the issued and outstanding common shares of the Company on the basis of ten (10)... Read More
MONTREAL , Nov. 30, 2022 /PRNewswire/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec , today announced that the Company filed with the TSX Venture Exchange ("the "TSX-V") a Notice in respect of a... Read More
GreenStockNews
Company recorded a record high of $12 million in quarterly revenue (84% YoY increase) and Net Income of $2.6 million Full year revenues were $36 million , a 108% increase compared to 2021 Delivered its sixth consecutive quarter of positive Adjusted EBITDA of $2.5M , and $5.3M for fiscal year 2022 All financial results are... Read More
Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a Quebec -based, vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices, announced today that it will be releasing 14 new SKU's of its premium-grade cannabis in Ontario and Quebec under the Company's flagship brands, Tribal, Nugz, and Orchid CBD brands. Brand Product Name... Read More
Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a Quebec -based, vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices, today announced its entry into the British Columbia (BC) market. In addition, the Company is also pleased to announce the launch of its first two premium product offerings in the vape and accessory categories.... Read More
Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec , announced that on August 31, 2022 , Derek Stern , a director and principle shareholder owning more than 10% of the issued and outstanding common... Read More
Cannara Biotech Inc . ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada , and the largest in Quebec , today announced that it will host a webcast investor presentation on Wednesday, August 17 th , 2022, at 2:00 PM ET . During the webcast, Nicholas... Read More
GreenStockNews
Agreement grants Cannara an exclusive license to use, sell and distribute Exotic Genetix branded products throughout Canada in addition to providing access to direct breeder's knowledge and insights on Exotic Genetix' cannabis strains Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a... Read More
GreenStockNews
Company recorded a record high of $10.1 million in quarterly revenue and $24.1 million in year-to-date revenue, delivering its fifth consecutive quarter of positive Q3 2022 Adjusted EBITDA of $1.8M with net income of $1.4 million Valleyfield Facility continues to scale, and the Company now has 6 of its 24 growing zones in full... Read More
Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., announced today that it has closed on a $50M credit facility led by BMO Commercial Banking. The credit facility, effective May 31, 2022 , includes a three-year term loan for $45... Read More
GreenStockNews
Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced the Company's Chief Financial Officer, Nicholas Sosiak ,... Read More
GreenStockNews
Company recorded $7.4 million in quarterly revenues and delivers fourth consecutive quarter of positive Adjusted EBITDA while continuing to rapidly scale production capacity at the Valleyfield Facility Completed first harvest from the Valleyfield Facility with positive market feedback consistent with the quality of products... Read More
GreenStockNews
Strong execution leads to third consecutive quarter of positive Adjusted EBITDA Company recorded quarterly revenues of $6.6 million Growing operations initiated at new Valleyfield Facility All financial results are reported in Canadian dollars, unless otherwise stated. Cannara Biotech Inc. (" Cannara " or the " Company ")... Read More
GreenStockNews
Company invites individual and institutional investors, as well as advisors and analysts, to attend a real-time, interactive presentation on VirtualInvestorConferences.com Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and... Read More
GreenStockNews
Fiscal 2021 revenues of $17.3 million , gross profit of $10.5 million or 61% and an Adjusted EBITDA of $1.5 million , strong indicators of Cannara's performance and successful operating strategy All financial results are reported in Canadian dollars, unless otherwise stated. Cannara Biotech Inc. (" Cannara " or the " Company... Read More
GreenStockNews
Refinancing will decrease the Company's overall debt servicing costs to 4.3% Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega cultivation facilities based in Québec spanning over... Read More
GreenStockNews
10 000 plants to be propagated in the re-designed Valleyfield zones to replicate indoor growing conditions Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega cultivation facilities based... Read More
Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two Quebec -based mega cultivation facilities spanning over 1,650,000 sq. ft., today announced it has received an amendment of its License from Health Canada, permitting the sale of Cannabis 2.0 products for which the Company intends to use to... Read More
GreenStockNews
Third quarter revenue of $7.2 million , gross profit of $4.4 million , and net income of $1.7 million showcases success of market strategy and operating model Cannara Biotech Inc. ( "Cannara" or the "Company" ) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative... Read More
Cannara Biotech Inc. ( "Cannara" or the "Company" ) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium–grade cannabis and derivative products with two Quebec–based mega cultivation facilities spanning over 1,650,000 sq. ft., today announced that it has closed an additional $5 million private placement at an issue price per share of $0.18 , resulting in the issuance of 27,777,778 new common... Read More
GreenStockNews
Preliminary results from first commercial quarter in market show successful market launch in Quebec Cannara Biotech Inc. ( "Cannara" or the "Company" ) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), is pleased to announce preliminary unaudited revenue results for the three-month period ended May 31, 2021 , marking the retail debut... Read More
GreenStockNews
Newly built fully automated one million sq. ft. facility increases Company's capacity of premium-grade cannabis up to 125,000 kg annually Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of... Read More
GreenStockNews
Newly built fully automated one million sq. ft. facility increases Company's capacity of premium-grade cannabis up to 125,000 kg annually Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of... Read More
GreenStockNews
Significant second quarter revenue generation of $1.2 million and gross profit increase to $2.1 million showcases Cannara's positive trajectory Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of indoor cannabis and derivative products with one of... Read More
TSXV market listing anticipated to improve visibility of Cannara among the investor community Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade indoor cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec , today announced its common shares will be listed on... Read More
GreenStockNews
Anticipated TSXV market listing coincides with the appointment of Nicholas Sosiak to CFO and retail market debut Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated Quebec -based producer of premium-grade indoor cannabis and derivative products with one of the... Read More
GreenStockNews
Cannara's three new brands – Tribal, Nugz and Orchid CBD Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of indoor cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec , today... Read More
- Expects to generate revenue from letter of intent with the Société québécoise du cannabis by end of February or early March 2021 - Cannara Biotech Inc. (" Cannara " or the " Company ") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is pleased to announce its financial results for the three-month period ended November 30, 2020 . Unless otherwise noted, all dollar amounts are expressed in Canadian dollars. Q1 2021 OPERATIONAL... Read More

COPYRIGHT ©2022 GREEN STOCK NEWS